| Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization. | |
| | |
MedLine Citation:
|
PMID: 11755279 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: This study was designed to investigate the use of magnetic resonance (MR) functional and perfusion imaging to evaluate laser myocardial revascularization (LMR). BACKGROUND: Most clinical studies of LMR have shown improvements in angina class and exercise capacity, with minimal or absent improvements in myocardial perfusion and function. METHODS: Fifteen patients who underwent percutaneous Biosense-guided holmium:yttrium aluminum garnet LMR to areas of viable but ischemic myocardium were followed clinically and underwent functional and perfusion MRI at baseline, 30 days and 6 months. RESULTS: The mean age was 64 +/- 11 years; four patients were women. The ejection fraction was 47.4 +/- 14.0%. Angina class at baseline was 3.4 +/- 0.6 and improved to 2.5 +/- 1.4 at six months (p = 0.054). Exercise time at baseline was 298 +/- 97 s and increased to 350 +/- 95 s at 30 days and 365 +/- 79 s at six months, p = 0.04. There were no significant changes in nuclear perfusion scans. Although MR determined that resting radial motion and thickening of the target wall were significantly less than normal at baseline (p < 0.001), they improved significantly during follow-up (wall thickening: baseline, 30.6 +/- 11.7%; day 30, 41.2 +/- 13.3% and day 180, 44.2 +/- 11.9%, p = 0.01). The size of the underperfused myocardial area was 14.5 +/- 5.4% at baseline and was reduced to 6.3 +/- 2.8% at 30 days and 7.7 +/- 3.7% at 6 months (p < 0.001). CONCLUSIONS: This small phase I, open-label, uncontrolled study of MR functional and perfusion imaging in patients undergoing Biosense-guided LMR suggests a beneficial effect of this treatment strategy on myocardial function and perfusion. The efficacy of Biosense-guided LMR is being evaluated in a large phase II, randomized, blinded placebo-controlled trial with an MRI substudy (DIRECT). |
| | |
Authors:
|
Roger J Laham; Michael Simons; Justin D Pearlman; Kalon K L Ho; Donald S Baim |
Related Documents
:
|
195309 - The efficacy of thallium 201, 99mtc phosphates, and 99mtc maa in localizing small myoca... 2389839 - Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patient... 8960629 - Clinical applications of myocardial perfusion assessments made with oxygen-15 water and... 8854839 - Long-term cigarette smoking is associated with increased myocardial perfusion heterogen... 16915529 - Assessment of no-reflow regions using cardiac mri. 15488089 - Hemodynamic instability after receiving intravenous perflutren for contrast echocardiog... 12436749 - History of cardiac physiology in the framework of the german society for circulation re... 15735569 - Modified mid america heart institute coronary care unit scoring system--a new comprehen... 15769699 - Prototype epicardial crawling device for intrapericardial intervention on the beating h... |
Publication Detail:
|
Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 39 ISSN: 0735-1097 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 2002 Jan |
Date Detail:
|
Created Date: 2001-12-28 Completed Date: 2002-01-24 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 1-8 Citation Subset: AIM; IM |
Affiliation:
|
Angiogenesis Research Center, Harvard Medical School, Boston, Massachusetts 02115, USA. rlaham@bidmc.harvard.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Female Humans Laser Therapy* Magnetic Resonance Imaging* Male Middle Aged Myocardial Contraction* Myocardial Ischemia / physiopathology, surgery* Myocardial Revascularization* |
| Grant Support | |
ID/Acronym/Agency:
|
HL 56993/HL/NHLBI NIH HHS; HL53793/HL/NHLBI NIH HHS; HL63609/HL/NHLBI NIH HHS; M01-RR01032/RR/NCRR NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Release of chemical permeation enhancers from drug-in-adhesive transdermal patches.
Next Document: Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.